C
CNSP
CNS Pharmaceuticals
5.35
0.000.00%Opening19:30 10/08 EDT
OPEN/PREV CLOSE--/5.35
TODAY RANGE-
VOL0
MARKET CAP7.82M
52 WEEK RANGE1.900-10.59
AVG VOL (3M)6.43K
% TURNOVER0.12%
TURNOVER--
P/E (TTM)-0.2312
% RANGE4.97%
EPS(TTM)-23.1416
P/E(FORWARD)-3.2424
P/B0.4296
BVPS12.45
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.74M
SHARES OUTSTANDING1.46M
NEXT EARNINGS11/12-11/16
FREE FLOAT1.45M
LOT SIZE1
EX-DATE07/22/2025
News
Press Releases
Financial Reports
Profile
TipRanks·10/02 12:29
CNS Pharmaceuticals Shareholders Approve Key Governance Measures
Benzinga·09/02 12:07
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
TipRanks·09/01 13:20
CNS Pharmaceuticals details business development strategy
TipRanks·08/19 02:12
Insider Move at CNS Pharmaceuticals Sparks Investor Buzz
NASDAQ·08/18 17:57
CNSP Q2 Loss Widens As $22.5M Financing Fuels Strategic Pipeline Pivot
TipRanks·08/17 09:41
CNS Pharmaceuticals reports Q2 EPS (37c) vs. ($6.42) last year
Seeking Alpha·08/12 12:05
CNS Pharmaceuticals GAAP EPS of -$0.37 misses by $0.13
Benzinga·07/14 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
TipRanks·07/02 11:58
CNS Pharmaceuticals Announces Strategic Oncology-Neurology Realignment
Benzinga·07/01 12:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·05/26 12:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
TipRanks·05/21 02:09
Insider Boost: CNS Pharmaceuticals Director Quietly Ramps Up His Stake
TipRanks·05/19 21:01
CNS Pharmaceuticals files to sell 9.79M shares of common stock for holders
TipRanks·05/15 13:26
Maxim Group Sticks to Their Buy Rating for CNS Pharmaceuticals (CNSP)
Same Industry
Name/Symbol
Change%
Price